Arch Esp Urol 2017 Jun;70(5):525-533
Residente de Urología. Hospital Universitario Reina Sofía.Córdoba. España.
Download full-text PDF
J Vasc Interv Radiol 2005 May;16(5):679-88
The Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, 77030-4009, USA.
Purpose: To report the safety, technical success, and effectiveness of percutaneous radiofrequency (RF) ablation for renal tumors.
Materials And Methods: The authors retrospectively reviewed the medical records and imaging studies of 29 consecutive patients (18 men, 11 women; mean age, 65 +/- 2.62 years) with 30 renal tumors (mean diameter, 3. Read More
J Urol 2008 Sep 16;180(3):844-8; discussion 848. Epub 2008 Jul 16.
Department of Ultrasound, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Purpose: We evaluated the feasibility, safety and efficacy of ultrasound guided percutaneous microwave ablation for small renal cell cancers.
Materials And Methods: A total of 12 patients with a pathologically proven renal cell cancer 1.3 to 3. Read More
Radiologia 2010 May-Jun;52(3):228-33. Epub 2010 Apr 8.
Servicio de Radiología, Hospital Universitario Reina Sofía, Córdoba, España.
Objectives: To report our experience in percutaneous radiofrequency ablation of renal tumors, emphasizing technical aspects and indications and analyzing our results.
Material And Methods: We retrospectively analyzed 20 tumors in 13 patients (10 with a single kidney, 2 who had refused surgical treatment, and 1 with severe comorbidities). All procedures were carried out using the radiofrequency interstitial tumor ablation (RITA) technique under general anesthesia and CT guidance. Read More
Acta Radiol 2010 Sep;51(7):808-18
Department of Urology, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
Background: Treatment of small renal masses with percutaneous radiofrequency ablation (RFA) is under development. Data are limited regarding the oncologic efficacy and complication rates of ultrasound (US)-guided RFA.
Purpose: To retrospectively analyze results and factors predictive of incomplete ablation and local recurrence in patients treated for small renal tumors with US-guided percutaneous RFA. Read More